1. Woodward OM*, Köttgen A*, Coresh J, Boerwinkle E, Guggino WB, Köttgen M. Identification of a novel urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A, 2009 Jun 8. [Epub ahead of print].
2. Köttgen A*, Glazer NL*, Dehghan A*, Hwang SJ*, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Chen YI, de Boer IH, Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG, van Duijn CM, Chasman DI, Paré G, Ridker PM, Kao WHL, Witteman JC**, Coresh J**, Shlipak MG**, Fox CS**. Multiple Novel Loci are Associated with Indices of Renal Function and Chronic Kidney Disease. Nat Genet. 2009 May 10. [Epub ahead of print]
3. Selvin E, Köttgen A, Coresh J. Kidney Function Estimated from Serum Creatinine and Cystatin C and Peripheral Arterial Disease in NHANES 1999-2002. Eur J Heart, 2009 May 31. [Epub ahead of print]
4. Bash LD, Coresh J, Köttgen A, Parekh R, Fulop T, Wang Y, Astor BC. (2009) Definition of Incident Chronic Kidney Disease in the Research Setting: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol, in press.
5. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, Aulchenko Y, Lumley T, Köttgen A, Vasan RS, Rivadeneira F, Eiriksdottir G, Guo X, Arking DE, Mitchell GF, Mattace-Raso FUS, Smith AV, Taylor K, Scharpf RB, Hwang SJ, Sijbrands EJG, Bis J, Harris TB, Ganesh SK, O’Donnell CJ, Hofman A, Rotter JI, Coresh J, Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JCM, Boerwinkle E, Wang TJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, van Duijn CM. Association of Common Genetic Variants with Blood Pressure and Hypertension: A Genome-Wide Association Study of Six Population-based Cohort Studies, Replication, and Meta-analysis. Nat Genet. 2009 May 10. [Epub ahead of print]
6. Pfeufer A, Sanna S, Arking DE, Müller M, Gateva V, Ehret GB, Marroni F, Orrú M, Köttgen A, Perz S, Usala G, Barbalic M, Li M, Pütz P, Scuteri A, Prineus RJ, Sinner MF, Najjar S, Kao WHL, Mühleisen T, Dei M, Möhlenkamp S, Crisponi L, Jöckel K-H, Naitza S, Steinbeck G, Hicks A, Pramstaller P, Lakatta E, Müller-Myhsok B, Post W, Wichmann H-E, Schlessinger D, Boerwinkle E, Meitinger T, Uda M, Coresh J, Kääb S, Abecasis GR, Chakravarti A. Common variants in ten loci modulate QT interval duration in individuals of European ancestry. Nat Genet. 2009 Apr;41(4):407-14.
7. Dehghan A*, Köttgen A*, Yang Q*, Hwang SJ, Kao WHL, Uitterlinden AG, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC*, Coresh J*, Fox CS*. Association of Three Genetic Loci with Uric Acid Levels and Gout Risk. (*equal contribution) Lancet. 2008 Dec 6;372(9654):1953-61.
8. Pazin Filho A, Köttgen A, Bertoni AG, Russell SD, Selvin E, Rosamond WD, Coresh J. Hemoglobin A1c as a Risk Factor for Heart Failure in Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia. 2008 Dec;51(12):2197-204.
9. Köttgen A, Hsu CC, Coresh J, Shuldiner AR, Berthier-Schaad Y, Gambhir TR, Smith MW, Boerwinkle E, Kao WH. The association of podocin R229Q polymorphism with increased albuminuria or reduced estimated GFR in a large population-based sample of U.S. adults. Am J Kidney Dis. 2008 Nov;52(5):868-875.
10. Groesbeck D, Köttgen A, Selvin E, Coresh J, Furth SL. (2008) Reference Ranges and Sources of Variation for Cystatin C in the Adolescent Population of the National Health and Nutrition Examination Survey (NHANES) III. Clin J Am Soc Nephrol. 2008 Nov;3(6):1777-85
11. Köttgen A, Hwang S, Rampersaud E, Coresh J, North KE, Pankow JS, Meigs JB, Florez JC, Levy D, Boerwinkle E, Shuldiner AR, Fox CS, Kao WH. TCF7L2 Variants Associate with CKD Progression and Renal Function in Population-based Cohorts. J Am Soc Nephrol, Oct;19(10):1989-99.
12. Yan Y, North KE, Ballantyne CM, Brancati FL, Franceschini N, Heiss G, Kottgen A, Pankow JS, Selvin E, West SL, Boerwinkle E. Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Context Specific Lifetime Risk of Type 2 Diabetes in African American and Caucasian Adults: The Atherosclerosis Risk in Communities Study. Diabetes. 2009 Jan;58(1):285-9.
13. Köttgen A, Kao WH, Hwang SH, Boerwinkle E, Yang Q, Levy D, Benjamin EJ, Larson M, Astor BC, Coresh J & Fox CS. Genome-Wide Association Study for Renal Traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet Jun 3;9:49.
14. Köttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J. (2008) Serum Cystatin C in the U.S.: the Third National Health and Nutrition Examination Survey. Am J Kidney Dis 51:385-394.
15. Kottgen A, Russell S, Loehr L, Crainiceanu C, Rosamond W, Chang P, Chambless L, Coresh, J. (2007) Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 18(4): 1307-15.
16. Waldegger S, Fakler B, Bleich M, Barth P, Hopf A, Schulte U, Busch AE, Aller SG, Forrest J, Greger R, Lang F. (1999) Molecular and functional characterization of sKCNQ1 potassium channel from rectal gland of Squalus acanthias. Eur J Physiol 437, 298-304.
17. Schreiber R, Hopf A, Mall M, Greger R, Kunzelmann K. (1999) The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator is required for inhibition of the epithelial Na+ channel. Proc Natl Acad Sci 96: 5310 - 5315.
18. Hopf A, Schreiber R, Mall M, Greger R, Kunzelmann K. (1999) CFTR inhibits the activity of epithelial Na+ channels carrying Liddle's syndrome mutations. J Biol Chem 274: 13894 -13899.
